News

Medtronic’s Reveal DX insertable cardiac monitor (ICM) has been designated by the Japanese government as a high-priority medical device, and is said to be the first insertable cardiac

Mr Zeher most recently served as president and CEO of Nutritional Laboratories International. Prior to joining Nutritional Labs, Mr Zeher was president and COO of Pharmaceutical Formulations. Mr

The proceeds from this financing are expected to fund additional commercialization, product development and clinical research efforts for the company, which serves the $4 billion spinal market. This

The SpineAlign vertebral body replacement system (VBR) is SpineWorks Medical’s first approved product that was designed for a transpedicular, minimally-invasive approach to vertebral body reconstruction and anterior spinal

Orchem has registered Spectrum 24 with the US Environmental Protection Agency as a sub-registrant of Pure Bioscience and is currently undergoing registration in all 50 states. In accordance

The study is designed to determine the maximum tolerated dose and to establish the recommended dose and dosing schedule for Phase II trials, and will evaluate the safety

Light Sciences Oncology (LSO) plans to use the funds in the continued development of Light Infusion Therapy (Litx), which includes two ongoing Phase III clinical trials in patients

The agreement, which initially runs over five years, has a total estimated value of approximately RMB61.5 million. To date, China Sky One has been selling five of its

Dr Stamler brings to XenoPort over 15 years of clinical development experience, most recently serving as the chief scientific officer and head of drug development for Prestwick Pharmaceuticals.